← All trials
NCT01264445
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2011
- Primary completion
- Nov 1, 2012
- Completion date
- Nov 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 147
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- International AIDS Vaccine InitiativeLead sponsor
- Kenya AIDS Vaccine InitiativeOverall official - principal investigator
- Medical Research Council-UVRI Uganda Research Unit on AIDSOverall official - principal investigator
- Zambia-Emory HIV Research ProjectOverall official - principal investigator
- Uganda Virus Research InstituteOverall official - principal investigator
- GlaxoSmithKlineCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.